Achieve better results, faster. Automate your end-to-end pipelines with the Cytobank Platform via The Cytobank API. The Cytobank API extends the power of the Cytobank Cloud to any software application. Now bench scientists can more seamlessly interact with computational biologists and reviewers to assess results of internal algorithms and pipelines.
Every month, leading researchers investigate, discover, and publish new findings with the help of the Cytobank’s tools, platform, and community. Here are just a few papers of interest from the past few months: More »
Come visit the Cytobank team at FOCiS and CYTO next week to learn more about what we’ve been up to, for some hands-on help, to share your wish list or just to chit-chat. We look forward to seeing you there!
Check out the various talks and posters at CYTO featuring Cytobank:
Saturday June 27, 2015
11:00 (Room: Alsh) – The First Multi-center Comparative Study Using a Novel Technology Mass Cytometry Time-of-Flight Mass Spectrometer (CyTOF2) for High-Speed Acquisition of Highly Multi-parametric Single Cell Data: A Status Report A. Nasaar, B. Carter, J. Lannigan, R. Montgomery, N. Paul, M. Poulin, K. Raddassi, A. Rahman and N. Rashidi. Yale Univ. Sch. of Med., Stanford Shared FACS Facilities, Univ. of Virginia Sch. of Med., Dana-Farber Cancer Inst., Fluidigm, Cambridge, MA, Icahn Sch. of Med. at Mount Sinai and Ragon Inst. of MGH, MIT and Harvard.
11:40 (Room: Alsh) – High Content Dissection of Human Melanoma Tumor Heterogeneity during Treatment Using Mass Cytometry J. Irish, D. Doxie, A. Greenplate, K. Diggins, H. Polikowsky, K. Dahlman, J. Sosman and M. Kelley. Vanderbilt Univ. Sch. of Med.
Cytobank 5.0 is on its way to customer sites, and includes sweeping ease-of-use updates driven by customer feedback, enabling you to reach your goal faster. We’ve implemented a three-level system, centralizing site-wide, experiment-wide, and page-specific actions and reducing time-to-goal.
Welcome to Cytobank User Stories, a series featuring interviews with Cytobank users on their research, scientific vision, and use of fluorescence and mass cytometry.
This time we interview Erica Alvendia, a Research Associate at Primity Bio in Fremont, California. We asked Erica to share with us her favorite features from our 4.2 release and to describe how this release has helped to improve her scientific workflow.
|What are you excited about in science? What is your scientific vision?|
Science has such a broad subject range that there is always something new to learn. The knowledge you can obtain seems endless and that’s what I find exciting. More specifically, I’m fascinated with reading up on the pathogenesis of various diseases (especially the rare ones) and learning about the different treatments available for them. With that said, it’s my scientific vision to find treatment options for diseases that have none. Primarily any disease that results in either a physical or mental disability.
The Cytobank team has been working diligently to provide top tier analysis solutions for our users; viSNE in Cytobank is our most recent addition and we are very excited about what it has to offer.
What is viSNE? And how does it work?
viSNE is a tool for reducing high-parameter data down to two dimensions, making it easy for scientists to not only visually identify interesting and rare biological subsets, but also gate single cell events across different samples.
With the recent rise in cytometry data post-processing (e.g., normalization, debarcoding, concatenation), we at Cytobank have seen many FCS files that do not conform to the ISAC specification, and some of these variations in file writing may lead to downstream errors. As a result, we’ve implemented a Quality Control validator, built into Cytobank, that determines the compliance of your FCS files compared with the specification.
Greetings Cytobank community!
We have launched a weekly webinar series designed to give you an overview of Cytobank functionality, where you will have the option to ask your burning Cytobank questions. We’ll present a brief overview of the platform in slide format, and then walk you through the analysis of an actual dataset using Cytobank. You’ll have the opportunity to privately ask your questions via the webinar chat box and we will address them at the end. The series will be on an alternating weekly schedule where we rotate covering basic analysis and advanced topics such as SPADE.
View the schedule of upcoming webinars on our Upcoming Meetings page.
– The Cytobank Team